A study of the proteome of the intermediate-stage colorectal cancer cell line Caco2 revealed that the mutant KRAS (V12) contributed to an increased H-Ras protein level, indicating that HRAS might be a pivotal factor involved in the effects of KRAS mutation 26. The gene discussed is KRAS; the disease is colorectal cancer.